Literature DB >> 15694341

Ribosome stalling regulates IRES-mediated translation in eukaryotes, a parallel to prokaryotic attenuation.

James Fernandez1, Ibrahim Yaman, Charles Huang, Haiyan Liu, Alex B Lopez, Anton A Komar, Mark G Caprara, William C Merrick, Martin D Snider, Randal J Kaufman, Wouter H Lamers, Maria Hatzoglou.   

Abstract

It was previously shown that the mRNA for the cat-1 Arg/Lys transporter is translated from an internal ribosome entry site (IRES) that is regulated by cellular stress. Amino acid starvation stimulated cat-1 translation via a mechanism that requires translation of an ORF in the mRNA leader and remodeling of the leader to form an active IRES (the "zipper model" of translational control). It is shown here that slowing of the leader peptide elongation rate, either by cycloheximide or the introduction of rare codons, stimulated translation of the downstream ORF. These results suggest that ribosome stalling in the upstream ORF causes mRNA remodeling and formation of an active IRES. This control is reminiscent of translation attenuation in prokaryotic operons, where inhibition of translation elongation can regulate both mRNA translation and gene transcription by altering mRNA structure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694341     DOI: 10.1016/j.molcel.2004.12.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  38 in total

1.  Unorthodox mRNA start site to extend the highly structured leader of retrotransposon Tto1 mRNA increases transposition rate.

Authors:  Gudrun Böhmdorfer; Ivo L Hofacker; Karin Garber; Srecko Jelenic; Viktoria Nizhynska; Hirohiko Hirochika; Peter F Stadler; Andreas Bachmair
Journal:  RNA       Date:  2005-08       Impact factor: 4.942

Review 2.  Reprogramming mRNA translation during stress.

Authors:  Satoshi Yamasaki; Paul Anderson
Journal:  Curr Opin Cell Biol       Date:  2008-03-20       Impact factor: 8.382

Review 3.  Structure and function of cationic amino acid transporters (CATs).

Authors:  E I Closs; J-P Boissel; A Habermeier; A Rotmann
Journal:  J Membr Biol       Date:  2007-04-06       Impact factor: 1.843

Review 4.  New Insights into the Functions of Nucleic Acids Controlled by Cellular Microenvironments.

Authors:  Saki Matsumoto; Naoki Sugimoto
Journal:  Top Curr Chem (Cham)       Date:  2021-03-30

5.  Arabidopsis ribosomal proteins control developmental programs through translational regulation of auxin response factors.

Authors:  Abel Rosado; Ruixi Li; Wilhelmina van de Ven; Emily Hsu; Natasha V Raikhel
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-09       Impact factor: 11.205

Review 6.  Host detection of pathogen-induced translational inhibition: a new pathogen-specific branch of the innate immune system?

Authors:  Emily Troemel
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

7.  A cross-kingdom internal ribosome entry site reveals a simplified mode of internal ribosome entry.

Authors:  Ilya M Terenin; Sergei E Dmitriev; Dmitri E Andreev; Elizabeth Royall; Graham J Belsham; Lisa O Roberts; Ivan N Shatsky
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  Conserved regional 3' grouping of rare codons in the coding sequence of ocular prosecretory mitogen lacritin.

Authors:  Robert L McKown; Ronald W Raab; Patricia Kachelries; Sara Caldwell; Gordon W Laurie
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-19       Impact factor: 4.799

9.  Differential contribution of the m7G-cap to the 5' end-dependent translation initiation of mammalian mRNAs.

Authors:  Dmitri E Andreev; Sergey E Dmitriev; Ilya M Terenin; Vladimir S Prassolov; William C Merrick; Ivan N Shatsky
Journal:  Nucleic Acids Res       Date:  2009-08-20       Impact factor: 16.971

10.  Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs.

Authors:  Shuo Gu; Lan Jin; Feijie Zhang; Peter Sarnow; Mark A Kay
Journal:  Nat Struct Mol Biol       Date:  2009-02-01       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.